Product Images Bimatoprost

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Bimatoprost NDC 57297-429 by Lupin Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structure - 57e9781e 0066 417f 9253 6b2b079f3ec5 01

structure - 57e9781e 0066 417f 9253 6b2b079f3ec5 01

2.5 ml bottle - 57e9781e 0066 417f 9253 6b2b079f3ec5 02

2.5 ml bottle - 57e9781e 0066 417f 9253 6b2b079f3ec5 02

2.5 ml carton - 57e9781e 0066 417f 9253 6b2b079f3ec5 03

2.5 ml carton - 57e9781e 0066 417f 9253 6b2b079f3ec5 03

This is a prescription drug named Bimatoprost 0.03% with NF0.005% benzalkonium chloride as a preservative. Each bottle contains 2.5mL of liquid which is enough for a month of use. It's produced by Lupin Ltd. The medication requires one drop in the affected eye(s) every evening. It should be kept away from children and stored at room temperature.*

5 ml bottle - 57e9781e 0066 417f 9253 6b2b079f3ec5 04

5 ml bottle - 57e9781e 0066 417f 9253 6b2b079f3ec5 04

This is a description of a medication called Bimatoprost Ophthalmic Solution. It is a sterile solution for use in the eyes only and is available only with a prescription. The manufacturer is Lupin Limited and each mL of the solution contains bimatoprost (0.3mg) as an active ingredient and benzalkonium as a preservative. The recommended storage temperature is between 21-25°C. The article also includes details of the product code and manufacture date.*

5 ml carton - 57e9781e 0066 417f 9253 6b2b079f3ec5 05

5 ml carton - 57e9781e 0066 417f 9253 6b2b079f3ec5 05

LIRS Ophthalmic Solution is a sterile medication used in the eyes. Each bottle contains bimatoprost, an active ingredient of 0.03% (0.3mg). The solution also includes preservatives and inactives such as disodium hydrogen phosphate heptahydrate, citric acid monohydrate, and sodium chloride. It is advised to use one drop in the affected eye(s) once daily in the evening. The package is not child-resistant, so it should be kept out of the reach of children. The usual dosage of the medicine is mentioned on the accompanying prescription information. The LIRS Ophthalmic Solution is manufactured by Lupin Pharmaceuticals, which is located in Baltimore.*

7.5 ml bottle - 57e9781e 0066 417f 9253 6b2b079f3ec5 06

7.5 ml bottle - 57e9781e 0066 417f 9253 6b2b079f3ec5 06

This is a description of an ophthalmic solution manufactured by Lupin Limited. The solution contains bimatoprost 0.03% as the active ingredient and benzalkonium chloride NF 0.005% as the preservative. The solution is indicated for use in the eyes only and the usual dosage instructions can be found in the package insert. The solution should be stored at 21-25°C.*

7.5 ml carton - 57e9781e 0066 417f 9253 6b2b079f3ec5 07

7.5 ml carton - 57e9781e 0066 417f 9253 6b2b079f3ec5 07

This is a product description for Bimatoprost Ophthalmic Solution, manufactured by Lupin Pharmaceuticals, intended for use in the eyes only. The solution contains 0.03% (0.3 mg) of the active ingredient Bimatoprost and benzalkonium chloride as a preservative. The other ingredients include disodium hydrogen phosphate heptahydrate, citric acid monohydrate, sodium chloride, and water for injection. The dosage involves administering one drop in the affected eye(s) once a day in the evening. More information can be found in the accompanying prescribing information. Store the product at a temperature of 2 to 25°C, and keep it away from children as the package is not child-resistant. The listed manufacturer's address is Lupin Pharmaceuticals, Baltimore, Maryland, and is sterile.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.